See Graham's ranking
4.0
DaVita Inc. operates within the healthcare sector, specifically in the renal care and dialysis services subsector, with its shares traded on the New York Stock Exchange (NYSE) under the ticker DVA. The company’s corporate formation is associated with U.S. healthcare investors and executives, initially motivated by the provision of specialized renal replacement therapies and care for patients with chronic kidney disease.
The portfolio of products and services includes hemodialysis, peritoneal dialysis, patient education programs, chronic care management, inpatient services, renal rehabilitation, and integrated case-management solutions supported by multidisciplinary clinical teams.
Its market presence is predominantly domestic, operating across multiple U.S. states through company-owned clinics, operational units, and contractual partnerships with hospitals and medical service providers. Operations serve dialysis patients, health plans, government agencies, and organizations that require specialized renal therapy services.
Relevant market factors include demographic aging trends, rising prevalence of kidney disease, competition among dialysis providers, federal and state regulatory frameworks, Medicare and Medicaid reimbursement policies, and advances in therapeutic technologies. Operational cost dynamics, regulatory capital requirements, and compliance practices influence planning processes and operating margins.
The operational scale comprises an extensive network of dialysis centers treating hundreds of thousands of patients annually, specialized clinical teams, and substantial volumes of hemodialysis and peritoneal dialysis treatments, along with integration into regional healthcare systems. The active patient base reflects significant participation in the U.S. renal therapy market.
The operational structure includes corporate headquarters in Denver, Colorado, clinical units across multiple states, divisions overseeing clinical operations, medical equipment logistics, human resources management, regulatory compliance, and information technology. Operational management models encompass standardized clinical protocols, patient scheduling systems, supply-chain logistics, and integration with healthcare providers.
The operating model combines specialized clinical services, care-management programs, patient education support, administrative billing and compliance services, and coordination with health plans. Operational strategy incorporates process standardization, continuous quality improvement, and integration of clinical data. The primary trading ticker is DVA, listed on the NYSE.
History and foundation
DaVita Inc. was founded in 1979 in Los Angeles, California, with an initial focus on delivering dialysis services to patients with chronic kidney disease, aiming to provide a more efficient and accessible alternative to traditional hospital-based treatment models.In its early years, challenges included developing adequate clinical infrastructure, acquiring specialized dialysis equipment, hiring trained medical professionals, and establishing clinical protocols aligned with regulatory requirements. Initial achievements involved opening clinical units and consolidating specialized renal-care practices.
The expansion phase was marked by growth of its dialysis center network across multiple U.S. states, development of partnerships with hospitals and healthcare providers, and diversification of services through the inclusion of patient education programs and chronic-care management systems.
Key milestones include the 1994 initial public offering (IPO) on the NYSE, which enabled the company to access capital for accelerated expansion; subsequent acquisitions of regional dialysis networks; and integration of information technologies to improve clinical records and operational efficiency.
Between 2020 and 2024, relevant factors included changes in Medicare and Medicaid reimbursement policies affecting operating revenues, advances in renal therapies and home-dialysis modalities, investments in clinical digitalization, and adjustments to the service network in response to efficiency and quality-of-care demands. These dynamics influenced operational practices and long-term strategic positioning within the renal-care environment.
Additional Information
The Company DaVita Inc. (United States), is listed on NYSE with a market value of $ 7.54 Billions, having an equity of $ 1.34 Billion.
With a total of 69.000 employees, the company is listed in the sector of Health and categorized in industry of Health Services and Providers.
In the last 12 months the Company had a revenue of $ 13.32 Billions, which generated a profit in the amount of $ 771.92 Millions.
As for its main indicators, the Company has a P/E ratio of 9.77, a P/BV ratio of 5.62 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker DVA.
